Medical Research Finder

Loading…

© 2026 meRfi®

Medical Research Finder

Legal Notice
Privacy
Terms of Use

Gut microbiota / Evidence-based microbiome knowledge (incl. AI chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

AuthorsReferences (Sources)

meRfi® AI Chat

Probiotics (living agents) & Cardiovascular Diseases (CVD)

Welcome to meRfi-GM!

Please register to continue your trial period!

meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Register for a free trial

Navigation

Contents

Probiotics hold significant potential as a non-pharmacological intervention for the prevention and management of Cardiovascular Diseases (CVD). By improving gut health, modulating lipid profiles, reducing inflammation, and regulating blood pressure, probiotics can contribute to better cardiovascular outcomes. However, further research is essential to establish definitive guidelines and maximize their therapeutic potential.
Ghanavati et al. 2015 J ClinExc 4(Special Issue): 138-156 (Persian)
Antony & Ponce de Leon 2018 in: Probiotics - Current Knowledge and Future Prospects, ed. by Shymaa Enany, ISBN 978-1-78923-387-2
Nongrum et al. 2021 Sch J App Med Sci 9(6): 751-759
Zhai et al. 2022 Oxid Med Cell Longev. 2022: 3900835
Almeida et al. 2023 Front. …

References (Sources)

Effects of Gut Microbiota on Cardiovascular Diseases
Nongrum et al. 2021 Sch J App Med Sci 9(6): 751-759
Gut microbes in cardiovascular diseases and their potential therapeutic applications
Jin et al. 2020e
Review
Meta-analysis: effects of probiotic supplementation on lipid proﬁles in normal to mildly hypercholesterolemic individuals
Shimizu et al. 2015 PLoS ONE 10: e139795
Meta-Analysis
Probiotics and Its Relationship with the Cardiovascular System
Antony & Ponce de Leon 2018 in: Probiotics - Current Knowledge and Future Prospects, ed. by Shymaa Enany, ISBN 978-1-78923-387-2
Probiotics Bring New Hope for Atherosclerosis Prevention and Treatment
Zhai et al. 2022 Oxid Med Cell Longev. 2022: 3900835
Review
Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia
Xue et al. 2017 Scientific Reports 7: Article ID 45176
The potential links between human gut microbiota and cardiovascular health and disease - is there a gut-cardiovascular axis?
Almeida et al. 2023 Front. Gastroenterol. 2: 1235126
Review

AI Chat

5/29/2026

Chat with our artificial intelligence: